KAYS Stock Overview
Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Kaya Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.039 |
| 52 Week High | US$0.089 |
| 52 Week Low | US$0.027 |
| Beta | 0.60 |
| 1 Month Change | -5.91% |
| 3 Month Change | -12.46% |
| 1 Year Change | -30.35% |
| 3 Year Change | -91.70% |
| 5 Year Change | -96.29% |
| Change since IPO | -99.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| KAYS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 25.8% | -0.6% | 1.0% |
| 1Y | -30.4% | 10.6% | 21.9% |
Price Volatility
| KAYS volatility | |
|---|---|
| KAYS Average Weekly Movement | 19.9% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KAYS's share price has been volatile over the past 3 months.
Volatility Over Time: KAYS's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2 | Craig Frank | www.kayaholdings.com |
Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name.
Kaya Holdings, Inc. Fundamentals Summary
| KAYS fundamental statistics | |
|---|---|
| Market cap | US$864.74k |
| Earnings (TTM) | US$1.61m |
| Revenue (TTM) | US$196.29k |
0.5x
P/E Ratio4.4x
P/S RatioIs KAYS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KAYS income statement (TTM) | |
|---|---|
| Revenue | US$196.29k |
| Cost of Revenue | US$81.35k |
| Gross Profit | US$114.95k |
| Other Expenses | -US$1.49m |
| Earnings | US$1.61m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.073 |
| Gross Margin | 58.56% |
| Net Profit Margin | 820.04% |
| Debt/Equity Ratio | -52.8% |
How did KAYS perform over the long term?
See historical performance and comparison